Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05512780
Status:
UNKNOWN
Last Update Posted:
2022-08-23
First Post:
2022-08-22
Brief Title:
Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positiveHER2-negative Breast Cancer
Sponsor:
Organization:
Hebei Medical University Fourth Hospital